
LifeVest® Wearable Cardioverter Defibrillator (WCD)
1M+ patients protected1: the most used, studied, and proven wearable defibrillator
From the team behind the LifeVest® wearable defibrillator comes a range of solutions to support the care of acute cardiac patients. Our innovative and proven technologies have helped more than one million patients get back to living their lives.
LifeVest® Wearable Cardioverter Defibrillator (WCD)
1M+ patients protected1: the most used, studied, and proven wearable defibrillator
Heart Failure Management System (HFMS)
Reduce heart failure readmissions2: Early management so patients can live their lives
TherOx® SuperSaturated Oxygen (SSO₂) Therapy
Harness the healing power of SSO₂ Therapy to reduce the risk of heart failure3
WatchPAT® Home Sleep Apnea Test
Simple, accurate, reliable home sleep testing4,5
ZOLL offers a unique portfolio of novel technologies designed to deliver better insights and better outcomes for acute cardiac patient care. Most importantly, ZOLL is motivated to deliver solutions that get patients back to living their lives.
Starting with LifeVest, the world’s first wearable defibrillator, our cardiac management solutions have supported the care of more than one million patients for more than 20 years.
Heart to Heart with LifeVest patients Alan, James, Jenn, and Laura
Dr. Fahmi Farah and Anthony, HFMS (Heart Failure Management System) patient
Paula, LifeVest patient
1. Based on commercial data as of November 2022.
2. Boehmer, J, Cremer, S, Abo-Auda, W. et al. Impact of a Novel Wearable Sensor on Heart Failure Rehospitalization: An Open-Label Concurrent-Control Clinical Trial. J Am Coll Cardiol HF. 2024 Dec, 12 (12) 2011–2022. https://www.jacc.org/doi/10.1016/j.jchf.2024.07.022
3. Chen, et al. Catheter Cardiovasc Interv. 2020;1–7.
4. Carey, Sandra A., et al. “The utility of home sleep apnea testing in the advanced heart failure populations.” The American Journal of Cardiology, vol. 191, Mar. 2023, pp. 8–13.
5. Yalamanchali, Sreeya, et al. “Diagnosis of obstructive sleep apnea by Peripheral Arterial Tonometry.” JAMA Otolaryngology–Head & Neck Surgery, vol. 139, no. 12, 1 Dec. 2013, p. 1343.
Whether you’re a patient or provider, we’re here to answer your questions with 24/7 live support, and a range of other ways to help.
GET IN TOUCH